Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 15/20 | 0.62 |
| ▸ | MTOR | P42345 | 15/20 | 0.62 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.45 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.45 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10198415 | 0.89 | PIK3CA (0.66) | PIK3CAMTOR | |
| SCHEMBL6896098 | 0.85 | PIK3CA (0.47) | PIK3CAMTORALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL10195788 | 0.85 | PIK3CA (0.63) | PIK3CAMTORLMNACYP1A2CYP3A4 | |
| SCHEMBL10195797 | 0.85 | PIK3CA (0.64) | PIK3CAMTOR | |
| SCHEMBL10195781 | 0.85 | MTOR (0.65) | PIK3CAMTORRPS6KB1 | |
| SCHEMBL10195984 | 0.84 | PIK3CA (0.64) | PIK3CAMTORRPS6KB1 | |
| SCHEMBL10198370 | 0.84 | PIK3CA (0.46) | PIK3CAMTORRPS6KB1 | |
| SCHEMBL12137987 | 0.84 | HRH4 (0.49) | PIK3CAMTORRPS6KA3HRH4 | |
| SCHEMBL10195432 | 0.83 | PIK3CA (0.68) | PIK3CAMTORRPS6KB1 | |
| SCHEMBL10196564 | 0.82 | PIK3CA (0.53) | PIK3CAMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120028958-A1 | 5-ALKYNYL-PYRIMIDINES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028958-A1 | 5-ALKYNYL-PYRIMIDINES | MKI67, CCNA1, CCNT1 | PIK3CA 1435/4885MTOR 1358/4885RPS6KA3 541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.